Platelet function tests in bleeding disorders

Seminars in Thrombosis and Hemostasis

Volumn 42, Issue 3, 2016, Pages 185-190

  Lassila, Riitta ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

aggregation; bleeding disorders; platelet procoagulant activity

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR; COLLAGEN; FIBRIN; PROCOAGULANT; THROMBIN; THROMBOCYTE RECEPTOR; FIBRINOGEN RECEPTOR;

ARTICLE; BLEEDING DISORDER; BLOOD CELL COUNT; BLOOD CLOTTING PARAMETERS; BLOOD SMEAR; BLOOD VESSEL WALL; DIAGNOSTIC TEST; DRUG USE; EMERGENCY SURGERY; FAMILY HISTORY; GENETIC COUNSELING; HEMOSTASIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIGHT TRANSMISSION AGGREGOMETRY; LUMINESCENCE; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOCYTE RICH PLASMA; TRANSMISSION ELECTRON MICROSCOPY; WHOLE BLOOD AGGREGOMETRY; WOUND HEALING; BIOLOGICAL MODEL; BLOOD; BLOOD PLATELET DISORDERS; HEMORRHAGIC DISORDERS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; THROMBOCYTE;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; HEMORRHAGIC DISORDERS; HUMANS; MODELS, BIOLOGICAL; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET MEMBRANE GLYCOPROTEINS;

EID: 84958824846     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0036-1571307     Document Type: Article

References (31)

1. Golebiewska E. M., Poole A. W. Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev: 2015; 29 3 153 162
2. Svensson P. J., Bergqvist P. B., Juul K. V., Berntorp E. Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. Blood Rev: 2014; 28 3 95 102
3. Hurst B. S., Lange S. S., Kullstam S. M., et al. Obstetric and gynecologic challenges in women with Ehlers-Danlos syndrome. Obstet Gynecol: 2014; 123 3 506 513
4. Akkerman J. W. Thrombopoietin and platelet function. Semin Thromb Hemost: 2006; 32 3 295 304
5. Grozovsky R., Giannini S., Falet H., Hoffmeister K. M. Regulating billions of blood platelets: glycans and beyond. Blood: 2015; 126 16 1877 1884
6. Barsam S. J., Psaila B., Forestier M., et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood: 2011; 117 21 5723 5732
7. Ilveskero S., Siljander P., Lassila R. Procoagulant activity on platelets adhered to collagen or plasma clot. Arterioscler Thromb Vasc Biol: 2001; 21 4 628 635
8. Hoffbrand A. V., Moss P. AH. Bleeding disorders caused by vascular and platelet abnormalities. In: Hoffbrand A. V., Mos P. AH. eds. Essential Hematology. 8th ed. Oxford, United Kingdom Blackwell Publishing Ltd: 2011; 331 344
9. Favaloro E. J. Internal quality control and external quality assurance of platelet function tests. Semin Thromb Hemost: 2009; 35 2 139 149
10. Du V. X., Huskens D., Maas C., Al Dieri R., de Groot P. G., de Laat B. New insights into the role of erythrocytes in thrombus formation. Semin Thromb Hemost: 2014; 40 1 72 80
11. Byrnes J. R., Duval C., Wang Y., et al. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. Blood: 2015; 126 16 1940 1948
12. Lassila R., Jouppila A. Mast cell-derived heparin proteoglycans as a model for a local antithrombotic. Semin Thromb Hemost: 2014; 40 8 837 844
13. Marcus A. J., Broekman M. J., Drosopoulos J. H., et al. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost: 2005; 31 2 234 246
14. Scharf R. E. Drugs that affect platelet function. Semin Thromb Hemost: 2012; 38 8 865 883
15. Tutwiler V., Madeeva D., Ahn H. S., et al. Platelet transactivation by monocytes promotes the prothrombotic state in heparin-induced thrombocytopenia. Blood: 2016; 127 4 464 472
16. Liebman H. A. Viral-associated immune thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program): 2008; 1 212 218
17. Laine O., Joutsi-Korhonen L., Lassila R., et al. Hantavirus infection-induced thrombocytopenia associates with impaired platelet aggregation but increases platelet production and secures platelet deposition under blood flow. Thromb Res: 2015; (6); 136 1126 1132
18. Zaffuto B. J., Conley G. W., Connolly G. C., et al. ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion. Vox Sang: 2015;; 10.1111/vox.12354 (e-pub ahead of print)
19. Phillips D. R., Teng W., Arfsten A., et al. Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate. Circulation: 1997; 96 5 1488 1494
20. Peerschke E. I., Castellone D. D., Stroobants A. K., Francis J. Reference range determination for whole-blood platelet aggregation using the Multiplate analyzer. Am J Clin Pathol: 2014; 142 5 647 656
21. Duncan E. M., Bonar R., Rodgers S. E., Favaloro E. J., Marsden K.; RCPA QAP in Haematology, Haemostasis Committee. Methodology and outcomes of platelet aggregation testing in Australia, New Zealand and the Asia-Pacific region: results of a survey from the Royal College of Pathologists of Australasia Haematology Quality Assurance Program. Int J Lab Hematol: 2009; 31 4 398 406
22. Gresele P., Harrison P., Bury L., et al. Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost: 2014; 12 9 1562 1569
23. Szántó T., Joutsi-Korhonen L., Deckmyn H., Lassila R. New insights into von Willebrand disease and platelet function. Semin Thromb Hemost: 2012; 38 1 55 63
24. Hayward C. PM, Pai M., Liu Y., et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost: 2009; 7 4 676 684
25. Estcourt L. J., Stanworth S. J., Harrison P., et al. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study. Br J Haematol: 2014; 166 4 581 591
26. Rand M. L., Perry D. W., Packham M. A., Gemmell C. H., Yeo E. L., Kinlough-Rathbone R. L. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression. Am J Hematol: 1996; 52 4 288 294
27. Israels S. J. Laboratory testing for platelet function disorders. Int J Lab Hematol: 2015; 37 01 18 24
28. Christie D. J., Avari T., Carrington L. R., et al. Platelet Function Testing by Aggregometry; Approved Guideline. CLSI document H58-A. Wayne, PA Clinical and Laboratory Standards Institute (CLSI): 2008
29. Wartiovaara-Kautto U., Joutsi-Korhonen L., Ilveskero S., Armstrong E., Lassila R. Platelets significantly modify procoagulant activities in haemophilia A. Haemophilia: 2011; 17 5 743 751
30. Colace T. V., Fogarty P. F., Panckeri K. A., Li R., Diamond S. L. Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels. J Thromb Haemost: 2014; 12 2 147 158
31. 12 receptor for adenosine diphosphate. Thromb Res: 2014; 133 2 254 256